Literature DB >> 19088077

Primary murine airway smooth muscle cells exposed to poly(I,C) or tunicamycin synthesize a leukocyte-adhesive hyaluronan matrix.

Mark E Lauer1, Durba Mukhopadhyay, Csaba Fulop, Carol A de la Motte, Alana K Majors, Vincent C Hascall.   

Abstract

Asthmatic attacks often follow viral infections with subsequent airway smooth muscle cell proliferation and the formation of an abnormal hyaluronan extracellular matrix with infiltrated leukocytes. In this study, we show that murine airway smooth muscle cells (MASM) treated with polyinosinic acid-polycytidylic acid (poly(I,C)), a double-stranded RNA that simulates a viral infection, synthesize an abnormal hyaluronan matrix that binds leukocytes (U937 cells). Synthesis of this matrix is initiated rapidly and accumulates linearly for approximately 10 h, reaching a plateau level approximately 7-fold higher than control cultures. MASM cells treated with tunicamycin, to induce endoplasmic reticulum stress, also rapidly initiate synthesis of the abnormal hyaluronan matrix with linear accumulation for approximately 10 h, but only reach a plateau level approximately 2-fold higher than control cultures. In contrast to poly(I,C), the response to tunicamycin depends on cell density, with pre-confluent cells producing more abnormal matrix per cell. Furthermore, U937 cell adhesion per hyaluronan content is higher in the sparse matrix produced in response to tunicamycin, suggesting that the structure in the poly(I,C)-induced matrix masks potential binding sites. When MASM cells were exposed to tunicamycin and poly(I,C) at the same time, U937 cell adhesion was partially additive, implying that these two toxins stimulate hyaluronan synthesis through two different pathways. We also characterized the size of hyaluronan produced by MASM cells, in response to poly(I,C) and tunicamycin, and we found that it ranges from 1500 to 4000 kDa, the majority of which was approximately 4000 kDa and not different in size than hyaluronan made by untreated cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088077      PMCID: PMC2643504          DOI: 10.1074/jbc.M807965200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

Review 1.  Asthma. From bronchoconstriction to airways inflammation and remodeling.

Authors:  J Bousquet; P K Jeffery; W W Busse; M Johnson; A M Vignola
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

Review 2.  Consequences of long-term inflammation. Airway remodeling.

Authors:  R J Homer; J A Elias
Journal:  Clin Chest Med       Date:  2000-06       Impact factor: 2.878

3.  Resolution of lung inflammation by CD44.

Authors:  Priit Teder; R William Vandivier; Dianhua Jiang; Jiurong Liang; Lauren Cohn; Ellen Puré; Peter M Henson; Paul W Noble
Journal:  Science       Date:  2002-04-05       Impact factor: 47.728

4.  Rhinoviruses infect the lower airways.

Authors:  N G Papadopoulos; P J Bates; P G Bardin; A Papi; S H Leir; D J Fraenkel; J Meyer; P M Lackie; G Sanderson; S T Holgate; S L Johnston
Journal:  J Infect Dis       Date:  2000-06-05       Impact factor: 5.226

Review 5.  Inflammatory cells in asthma: mechanisms and implications for therapy.

Authors:  Qutayba Hamid; Meri K Tulic'; Mark C Liu; Redwan Moqbel
Journal:  J Allergy Clin Immunol       Date:  2003-01       Impact factor: 10.793

6.  Hyaluronan serves a novel role in airway mucosal host defense.

Authors:  R Forteza; T Lieb; T Aoki; R C Savani; G E Conner; M Salathe
Journal:  FASEB J       Date:  2001-10       Impact factor: 5.191

7.  Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease.

Authors:  D R Ehlenfield; K Cameron; R C Welliver
Journal:  Pediatrics       Date:  2000-01       Impact factor: 7.124

8.  Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype.

Authors:  S J Hirst; C H Twort; T H Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2000-09       Impact factor: 6.914

9.  Interleukin-10 gene expression in acute virus-induced asthma.

Authors:  Terry V Grissell; Heather Powell; Darren R Shafren; Michael J Boyle; Michael J Hensley; Peter D Jones; Bruce F Whitehead; Peter G Gibson
Journal:  Am J Respir Crit Care Med       Date:  2005-05-13       Impact factor: 21.405

10.  Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study.

Authors:  Jonathan M Corne; Clare Marshall; Sandra Smith; Jacquie Schreiber; Gwendolyn Sanderson; Stephen T Holgate; Sebastian L Johnston
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

View more
  51 in total

Review 1.  The Inter-α-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.

Authors:  Megan S Lord; James Melrose; Anthony J Day; John M Whitelock
Journal:  J Histochem Cytochem       Date:  2020-07-08       Impact factor: 2.479

2.  Pathological Hyaluronan Matrices in Cystic Fibrosis Airways and Secretions.

Authors:  Brittany Matuska; Suzy Comhair; Carol Farver; James Chmiel; Ronald J Midura; Tracey Bonfield; Mark E Lauer
Journal:  Am J Respir Cell Mol Biol       Date:  2016-10       Impact factor: 6.914

3.  Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control.

Authors:  Nadine Nagy; Vivekananda G Sunkari; Gernot Kaber; Sonia Hasbun; Dung N Lam; Cate Speake; Srinath Sanda; Tracey L McLaughlin; Thomas N Wight; Steven R Long; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-09-06       Impact factor: 11.583

4.  Deficiency in the serum-derived hyaluronan-associated protein-hyaluronan complex enhances airway hyperresponsiveness in a murine model of asthma.

Authors:  Long Zhu; Lisheng Zhuo; Koji Kimata; Etsuro Yamaguchi; Hideto Watanabe; Mark A Aronica; Vincent C Hascall; Kenji Baba
Journal:  Int Arch Allergy Immunol       Date:  2010-05-18       Impact factor: 2.749

Review 5.  Hyaluronan fragments as mediators of inflammation in allergic pulmonary disease.

Authors:  Sumit Ghosh; Scott A Hoselton; Glenn P Dorsam; Jane M Schuh
Journal:  Immunobiology       Date:  2014-12-31       Impact factor: 3.144

6.  Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid Stimulation.

Authors:  Inkyung Kang; Ingrid A Harten; Mary Y Chang; Kathleen R Braun; Alyssa Sheih; Mary P Nivison; Pamela Y Johnson; Gail Workman; Gernot Kaber; Stephen P Evanko; Christina K Chan; Mervyn J Merrilees; Steven F Ziegler; Michael G Kinsella; Charles W Frevert; Thomas N Wight
Journal:  J Biol Chem       Date:  2016-11-28       Impact factor: 5.157

7.  Airway smooth muscle cells synthesize hyaluronan cable structures independent of inter-alpha-inhibitor heavy chain attachment.

Authors:  Mark E Lauer; Csaba Fulop; Durba Mukhopadhyay; Suzy Comhair; Serpil C Erzurum; Vincent C Hascall
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

8.  TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation.

Authors:  Stavros Garantziotis; Zhuowei Li; Erin N Potts; James Y Lindsey; Vandy P Stober; Vasiliy V Polosukhin; Timothy S Blackwell; David A Schwartz; W Michael Foster; John W Hollingsworth
Journal:  Am J Respir Crit Care Med       Date:  2009-12-10       Impact factor: 21.405

9.  Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion.

Authors:  Susan Potter-Perigo; Pamela Y Johnson; Stephen P Evanko; Christina K Chan; Kathleen R Braun; Thomas S Wilkinson; Leonard C Altman; Thomas N Wight
Journal:  Am J Respir Cell Mol Biol       Date:  2009-08-28       Impact factor: 6.914

10.  Chondrogenic capacity and alterations in hyaluronan synthesis of cultured human osteoarthritic chondrocytes.

Authors:  Yohei Ono; Tadahiro Sakai; Hideki Hiraiwa; Takashi Hamada; Takaaki Omachi; Motoshige Nakashima; Shinya Ishizuka; Tetsuya Matsukawa; Warren Knudson; Cheryl B Knudson; Naoki Ishiguro
Journal:  Biochem Biophys Res Commun       Date:  2013-05-20       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.